ArticleFrontiers in global women's health2026
Experiences of violence and the use of sleep-inducing medicines: a population-based study.
Article in Frontiers in global women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to verify the prevalence of sleep-inducing medicine use and its association with violence experiences among women. Methods: A cross-sectional study was conducted in 2022 in Vitória, Espírito Santo, Brazil, with 1,086 women aged 18 or older who had an intimate partner in the 24 months before the research. The outcome was the use of sleep-inducing medications and the independent variables was sociodemographic and economic characteristics, experiences of violence including, childhood sexual violence and intimate partner violence. We evaluated data descriptively, adopting 95% confidence intervals, Pearson's chi-square test or Fisher's exact test, and Poisson regression analysis. Results: The prevalence of lifetime use of sleep-inducing medicine was 37.2%, and the prevalence of current use was 18.4%. The lifetime or current use of sleep-inducing medicine was associated with age 60 years and above, not being in a marital relationship, having experienced sexual violence in childhood, and having suffered intimate partner violence (IPV) during their lifetime. Conclusion: We conclude that socioeconomic profile and exposure to violence are related to an increased odds of using sleep-inducing medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.